Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predictors of disease duration and symptom course of outpatients with acute covid-19: a retrospective cohort study

View ORCID ProfileJames B. O’Keefe, View ORCID ProfileElizabeth J. Tong, View ORCID ProfileGhazala A. Datoo O’Keefe, View ORCID ProfileDavid C. Tong
doi: https://doi.org/10.1101/2020.06.05.20123471
James B. O’Keefe
1Department of Medicine, Division of General Medicine and Geriatrics, Emory University School of Medicine, Atlanta, Georgia, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James B. O’Keefe
  • For correspondence: jbokeef@emory.edu
Elizabeth J. Tong
1Department of Medicine, Division of General Medicine and Geriatrics, Emory University School of Medicine, Atlanta, Georgia, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elizabeth J. Tong
Ghazala A. Datoo O’Keefe
2Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ghazala A. Datoo O’Keefe
David C. Tong
3Department of Medicine, Division of Hospital Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David C. Tong
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective Describe the disease course in a cohort of outpatients with covid-19 and evaluate factors predicting duration of symptoms

Design Retrospective cohort study

Setting Telemedicine clinic at a large medical system in Atlanta, Georgia

Participants 273 patients with COVID-19. Exclusion criteria included: (1) intake more than 10 days after symptom onset, (2) hospitalization for covid-19, (3) symptoms at less than two visits.

Main outcome measures Symptom duration in days

Results Common symptoms at diagnosis are upper respiratory (64% cough, 53% loss of smell or taste, 50% sinus congestion, 22% sore throat), systemic (50% headache, 48% body aches, 36% chills, 22% dizziness, 18% fever). The most frequent remaining symptoms at 30 days were cough (7%), loss of smell or taste (5%), body aches (5%), nasal congestion (5%), shortness of breath with exertion (5%), and joint pain (5%). Day of symptom onset was earliest for upper respiratory symptoms (mean 1.26 days, 95% confidence interval 1.15 to 1.4), followed by systemic symptoms (1.54, 1.39 to 1.7), with later onset of lower respiratory (2.86, 2.54 to 3.22) and gastrointestinal symptoms (3.46, 3.07 to 3.89), when present. Cough had the longest duration when present with 12.2 days (10.9 to 13.6). Loss of smell or taste had the second longest duration with 11.0 days (9.9 to 12.2). Provider-Assessed Symptom Severity (PASS) is the best predictor of symptom duration (P <0.005 for multiple symptoms) and patients with “Moderate” PASS compared to “Mild” at their intake visit have higher rates of symptoms at 30 days, including cough (12%), nasal congestion (10%), joint pain (10%), body aches (9%), loss of taste or smell (7%), headache (7%), and shortness of breath with exertion (6%).

Conclusions Covid-19 illness in outpatients follows a pattern of progression from systemic symptoms to lower respiratory symptoms and persistent symptoms are common across categories. Provider-assessed symptom severity is the best predictor of disease duration.

Competing Interest Statement

Dr. G. OKeefe served on an advisory board of Eyepoint Pharmaceuticals in 2019. It is unrelated to the current work.

Funding Statement

No external funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Emory University Institutional Review Board (STUDY00000766), which granted both a waiver of informed consent and a waiver of the Health Information Portability and Privacy Act as the study posed no more than minimal risk.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Additional analyses of (1) symptom duration by initial severity, (2) symptom onset timing

Data Availability

Deidentified data are available for sharing upon reasonable request.

https://dataverse.unc.edu/dataverse/VOMCTierStudy

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted August 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predictors of disease duration and symptom course of outpatients with acute covid-19: a retrospective cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predictors of disease duration and symptom course of outpatients with acute covid-19: a retrospective cohort study
James B. O’Keefe, Elizabeth J. Tong, Ghazala A. Datoo O’Keefe, David C. Tong
medRxiv 2020.06.05.20123471; doi: https://doi.org/10.1101/2020.06.05.20123471
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Predictors of disease duration and symptom course of outpatients with acute covid-19: a retrospective cohort study
James B. O’Keefe, Elizabeth J. Tong, Ghazala A. Datoo O’Keefe, David C. Tong
medRxiv 2020.06.05.20123471; doi: https://doi.org/10.1101/2020.06.05.20123471

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (202)
  • Anesthesia (55)
  • Cardiovascular Medicine (495)
  • Dentistry and Oral Medicine (91)
  • Dermatology (57)
  • Emergency Medicine (170)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (217)
  • Epidemiology (5753)
  • Forensic Medicine (3)
  • Gastroenterology (221)
  • Genetic and Genomic Medicine (883)
  • Geriatric Medicine (89)
  • Health Economics (233)
  • Health Informatics (777)
  • Health Policy (400)
  • Health Systems and Quality Improvement (258)
  • Hematology (105)
  • HIV/AIDS (187)
  • Infectious Diseases (except HIV/AIDS) (6587)
  • Intensive Care and Critical Care Medicine (397)
  • Medical Education (119)
  • Medical Ethics (29)
  • Nephrology (94)
  • Neurology (859)
  • Nursing (45)
  • Nutrition (143)
  • Obstetrics and Gynecology (166)
  • Occupational and Environmental Health (266)
  • Oncology (521)
  • Ophthalmology (168)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (22)
  • Pathology (150)
  • Pediatrics (258)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (116)
  • Psychiatry and Clinical Psychology (991)
  • Public and Global Health (2265)
  • Radiology and Imaging (380)
  • Rehabilitation Medicine and Physical Therapy (175)
  • Respiratory Medicine (314)
  • Rheumatology (110)
  • Sexual and Reproductive Health (83)
  • Sports Medicine (83)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)